Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block

NCT05543109 | Unknown

• 1 other identifier: 35635/8/22
• Study Type: interventional
• Target: 85
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study was to compare the intraoperative and the postoperative analgesic effect of psoas compartment block (PCB) and supra-inguinal fascia iliaca compartment block (SFIB) in pediatric patients undergoing developmental dysplasia of the hip

Conditions

Pain, Postoperative; Hip Dysplasia

Outcome Measures

Primary Outcomes (2)

• Intraoperative anesthetic requirement

  Intraoperative anesthetic requirement including intraoperative sevoflurane concentration and total fentanyl consumption

  1 hour

• Postoperative analgesic requirements

  Postoperative Ketoprofen and morphine consumption

  8 hours

Study Arms (2)

Psoas compartment block

ACTIVE COMPARATOR

After induction of anesthesia; ultrasound guided psoas compartment block will be done using ropivacaine 0.25% 1ml/kg.

Drug: Fentanyl; Drug: Propofol; Drug: Rocuronium; Drug: Sevoflurane; Drug: Ropivacaine

Suprainguinal fascia iliaca compartment block

ACTIVE COMPARATOR

After induction of anesthesia; ultrasound guided suprainguinal fascia iliaca compartment block will be done using ropivacaine 0.25% 1ml/kg.

Drug: Fentanyl; Drug: Propofol; Drug: Rocuronium; Drug: Sevoflurane; Drug: Ropivacaine

Interventions

Fentanyl DRUG

1 mic/kg during induction of anesthesia

Also known as: Narcotic

Psoas compartment block; Suprainguinal fascia iliaca compartment block

Propofol DRUG

3mg/kg during induction of anesthesia

Also known as: Intravenous anesthetic

Psoas compartment block; Suprainguinal fascia iliaca compartment block

Rocuronium DRUG

0.9 mg/kg during induction of anesthesia

Also known as: Muscle relaxant

Psoas compartment block; Suprainguinal fascia iliaca compartment block

Sevoflurane DRUG

2-3% during maintanance of anesthesia

Also known as: Inhalational anesthetic

Psoas compartment block; Suprainguinal fascia iliaca compartment block

Ropivacaine DRUG

0.25% Ropivacaine will be used at 1 ml/kg will be injected Ultrasound guided after induction of general anesthesia.

Also known as: Local anesthetic

Psoas compartment block; Suprainguinal fascia iliaca compartment block

Eligibility Criteria

• Age: 1 Year - 10 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Patients undergoing undergo acetabuloplasty
• Anesthesiologists (ASA) physical status of I to II

You may not qualify if:

• Known allergy to local anesthetic
• Infection at the block site.

Sponsors & Collaborators

• Tanta University: lead

Study Sites (1)

Mona Mohamed Mogahed

Tanta, Elgharbia, 31511, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative; Hip Dislocation

Interventions

Fentanyl; Narcotics; Propofol; Anesthetics, Intravenous; Rocuronium; Sevoflurane; Ropivacaine; Anesthetics, Local

Condition Hierarchy (Ancestors)

Postoperative Complications; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pain; Neurologic Manifestations; Signs and Symptoms; Joint Dislocations; Joint Diseases; Musculoskeletal Diseases; Wounds and Injuries; Hip Injuries

Intervention Hierarchy (Ancestors)

Piperidines; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds; Central Nervous System Depressants; Physiological Effects of Drugs; Pharmacologic Actions; Chemical Actions and Uses; Analgesics; Sensory System Agents; Peripheral Nervous System Agents; Central Nervous System Agents; Therapeutic Uses; Phenols; Benzene Derivatives; Hydrocarbons, Aromatic; Hydrocarbons, Cyclic; Hydrocarbons; Organic Chemicals; Anesthetics, General; Anesthetics; Androstanols; Androstanes; Steroids; Fused-Ring Compounds; Polycyclic Compounds; Methyl Ethers; Ethers; Hydrocarbons, Fluorinated; Hydrocarbons, Halogenated; Anilides; Amides; Aniline Compounds; Amines

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate professor

Study Record Dates

• First Submitted: September 13, 2022
• First Posted: September 16, 2022
• Study Start: September 29, 2022
• Primary Completion: February 10, 2023
• Study Completion: February 10, 2023
• Last Updated: September 30, 2022

Record last verified: 2022-09

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)